PLAAT3 and non-small cell lung carcinoma: Conversely, high expression of PLA2G16 has been reported to be associated with poor prognosis in non-small cell lung cancer patients and osteosarcomas suggesting its impact on tumor progression may be tumor type-specific [25, 26].